SHARE

Senior Lecturer Alexis Bailey has presented preliminary results from his observational study about e-cigarettes at SRNT, the top nicotine and tobacco research conference, which took place in Munich last month. The study titled “SmokeFreeBrain” looked at the effect that switching from smoking to vaping for 28 days, had on heavy smokers.

The 31 participants who completed the study were measured for several parameters including psychometric, cardiovascular, quality of life, brain activity and biomarkers of toxicity. The collected data indicated significant changes in psychometric parameters and a considerable reduction in biomarkers of toxicity. Additionally, in line with findings from previous research, switching from cigarettes to e-cigarettes, was seen to reduce not only the craving to smoke, but also exposure to nicotine and specific nitrosamines.

“Our preliminary findings support electronic cigarettes as an effective way of stopping smoking, quickly inducing beneficial changes in various measures of psychometric health and the craving to smoke.”Alexis Bailey, SmokeFreeBrain

“Our preliminary findings support electronic cigarettes as an effective way of stopping smoking, quickly inducing beneficial changes in various measures of psychometric health and the craving to smoke, said Dr. Bailey, adding, “Nonetheless, caution has to be taken over their use. E-cigarettes are not without risks and there is an ever-expanding growth of new products on the market.”

E-cigs are less addictive than regular cigarettes

A PATH study from 2017 by researchers from Penn State College of Medicine, had indicated that vapers are less dependent on their electronic devices, than smokers are on combustible cigarettes. The study which was funded by the National Institutes of Health and the Center for Tobacco Products, was based on an ongoing national survey of tobacco use.

The researchers had found that vapers tend to use their products later in the morning after waking up, in comparison to smokers. Additionally they were found to have less cravings, found it easier to refrain from using the products in restricted areas, and were less likely to consider themselves as addicts.

Read Further: Medical Press

Advertisement

Book your ad here